NIH Funds Second Round Of Controversial Chelation Tria

–TACT2 will test chelation in heart attack patients with diabetes. The NIH has agreed to fund a second round of a highly controversial study testing the possible benefits of chelation therapy in heart attack patients with diabetes. The second Trial to Assess Chelation Therapy (TACT2), now recruiting patients at more than 100 clinical sites, is...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: Diabetes People, Places & Events Policy & Ethics alternative medicine chelation diabetes drugs TACT Source Type: blogs